University of Oxford Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of Oxford Featured PhD Programmes
MRC Enterprise Studentship Programme 2020 (industrial CASE awards)

MRC Enterprise Studentship Programme 2021 (industrial CASE awards)

Four industrial CASE (iCASE) studentships are available for doctoral study at Oxford to start in October 2021. Each iCASE studentship is fully-funded for four years with a stipend of £20,000 p.a., all course fees paid, plus a research training support grant. The studentships will be based in the University as part of the Oxford-MRC Doctoral Training Partnership, and will also involve close collaboration with a commercial partner, including at least 3 months working at the company during the course of the DPhil project.

For full details, see: www.medsci.ox.ac.uk/study/graduateschool/mrcdtp/oxford-mrc-enterprise-studentships

Applications must be received by 12 noon (UK time) Friday 8 January 2021.

Project Details

The projects available are:

  1. Real-time benefit-risk assessment of vaccine exposure across a nationally representative primary care sentinel network: cutting edge technologies to prevent disease (Lead supervisor: Prof Simon de Lusignan; commercial partner: EMIS Group)
  2. Development of a bioelectronic system for applying chronobiology to improve the treatment of neurological disorders (Lead supervisor: Prof Tim Denison & Prof Colin Espie; commercial partner: Bioinduction)
  3. Modelling ocular drug retention technologies (Lead supervisor: Prof Eamonn Gaffney; commercial partner: Roche)
  4. Anti-S SOMAmers as functional probes and potential therapeutic agents for Covid19 (Lead supervisor: Prof William James; commercial partner: SomaLogic)
  5. Using Behavioural Insights to Improve Effectiveness of Digital Weight Loss Interventions (Lead supervisor: Prof Susan Jebb; commercial partner: Second Nature)
  6. A clinically relevant musculoskeletal humanoid shoulder for biomedical applications (Lead supervisor: Prof Pierre-Alexis Mouthuy; commercial partner: Devanthro GmbH)
  7. Optimising CAR-T efficacy in pancreatic cancer with bioengineered scaffolds and immune agonists (Lead supervisor: Prof Eric O’Neill; commercial partner: Oxford BioMedica
  8. Development and improvement of prediction /decision making tools in treating depression in primary care (Lead supervisor: Assoc Prof Kate Saunders & Prof Terry Lyons; commercial partner: P1vital Products)
  9. Enhancing health and well-being across the lifespan using bio-informed lighting in the built environment (Lead supervisor: Prof Hannah Smithson; commercial partner: Hoare Lea)
  10. Production of SARS-CoV-2 Subunit Vaccine in Pichia pastoris (Lead supervisor: Prof Alain Townsend & Dr Tiong Kit Tan; commercial partner: Ingenza)
  11. Development of Novel RF Coils for Hyperpolarized Magnetic Resonance Imaging (Lead supervisor: Prof Damian Tyler; commercial partner: PulseTeq)
  12. Dissecting the haematological and immune components of preeclampsia and their functional significance - the role of placental extracellular vesicles (Lead supervisor: Dr Manu Vatish; commercial partner: Sysmex)
  13. Clonal Basis of Response and Resistance to Combination Anti-Apoptotic Therapy in Patients With Acute Myeloid Leukaemia (Lead supervisor: Prof Paresh Vyas; commercial partner: Astra Zeneca)
  14. Hybrid nanoparticles of extracellular vesicles and adeno-associated viruses (AAVs) as an innovative gene-replacement therapy for rare monogenic diseases (Lead supervisor: Prof Matthew Wood; commercial partner: Evox Therapeutics)

How to Apply

Details on how to apply, entry requirements and eligibility can be found here. If you have any specific queries about the iCASE application process, please email mrc@medsci.ox.ac.uk.

All applications must be received by the deadline of 12 noon (UK time) Friday 8 January 2021.

Projects

A clinically relevant musculoskeletal humanoid shoulder for biomedical applicationsDetails
Anti-S SOMAmers as functional probes and potential therapeutic agents for Covid19Details
Clonal Basis of Response and Resistance to Combination Anti-Apoptotic Therapy in Patients With Acute Myeloid LeukaemiaDetails
Development and improvement of prediction /decision making tools in treating depression in primary careDetails
Development of a bioelectronic system for applying chronobiology to improve the treatment of neurological disordersDetails
Development of Novel RF Coils for Hyperpolarized Magnetic Resonance ImagingDetails
Dissecting the haematological and immune components of preeclampsia and their functional significance - the role of placental extracellular vesiclesDetails
Enhancing health and well-being across the lifespan using bio-informed lighting in the built environmentDetails
Hybrid nanoparticles of extracellular vesicles and adeno-associated viruses (AAVs) as an innovative gene-replacement therapy for rare monogenic diseasesDetails
Modelling ocular drug retention technologiesDetails
Optimising CAR-T efficacy in pancreatic cancer with bioengineered scaffolds and immune agonistsDetails
Production of SARS-CoV-2 Subunit Vaccine in Pichia pastorisDetails
Real-time benefit-risk assessment of vaccine exposure across a nationally representative primary care sentinel network: cutting edge technologies to prevent diseaseDetails
Using Behavioural Insights to Improve Effectiveness of Digital Weight Loss InterventionsDetails
MRC Enterprise Studentship Programme 2020 (industrial CASE awards)

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to this university will only be used by them to deal with your enquiry. For more information on how we use your data, please read our privacy statement

* required field

Your enquiry has been emailed successfully


×


FindAPhD. Copyright 2005-2020
All rights reserved.